Antiverse Ltd

Antiverse Ltd, based in Cardiff, UK, is a small, active company founded eight years ago in 2017. It employs eight people and holds £435,124 in assets. With seven directors and no owners reported, the company operates from a real address and regularly imports miscellaneous chemical products—the last import was recorded in February 9 2025. The company’s primary focus is research and experimental development within the biotechnology industry.

The company's website highlights its specialization in antibody design for challenging targets, leveraging generative AI. It emphasizes a partnership with Nxera Pharma and offers services including antibody discovery, design, and optimization. The site also features a team of experts with diverse backgrounds in antibody development, machine learning, and biotechnology. The site is well-designed and clearly communicates Antiverse’s value proposition.

Financially, Antiverse Ltd shows some concerning trends. Current assets have significantly decreased by 77% to £440,000, while net assets have fallen 90% to -£2.3 million. Bank borrowings have increased substantially, reaching £33,000, and cash reserves have plummeted 98% to a mere £30,000. Creditors have also increased, reaching £2.8 million. The company’s small size (meeting two of three criteria for a small company) allows for agility, but the sharp decline in equity suggests a need for additional funding. The number of employees has increased by 62%, to thirteen, which could be a sign of growth or increased operational costs. With no auditor mentioned, the figures rely on unaudited statements.

In short, Antiverse Ltd is facing financial pressures despite its innovative technology and partnerships. The company's focus on AI-driven antibody design shows promise, but sustaining growth will depend on securing additional investment and managing its expenses effectively.

Registered in England/Wales under the registration number 10736975, with a registered address at CF24 3SD, Wales, Cardiff, 34 Roath Court Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.